Evidence map›Paper›PMID 40979030›Full record

ArticleCureus2025

When Benign Turns Critical: Surgical Management of an Asymptomatic Renal Angiomyolipoma With Inferior Vena Cava and Right Cardiac Extension.

Jiehua Li, Lunchang Wang, Xin Li, Hao He, Chang Shu

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jiehua LiDepartment of Vascular Surgery, The Second Xiangya Hospital of Central South University, Changsha, CHN.
Lunchang WangDepartment of Vascular Surgery, The Second Xiangya Hospital of Central South University, Changsha, CHN.
Xin LiDepartment of Vascular Surgery, The Second Xiangya Hospital of Central South University, Changsha, CHN.
Hao HeDepartment of Vascular Surgery, The Second Xiangya Hospital of Central South University, Changsha, CHN.
Chang ShuDepartment of Vascular Surgery, The Second Xiangya Hospital of Central South University, Changsha, CHN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal angiomyolipoma (AML) is a benign mesenchymal tumor usually confined to the kidney, but rare cases exhibit aggressive behavior with extension into the inferior vena cava (IVC) and right atrium (RA), resulting in significant clinical challenges due to risks such as heart failure and pulmonary embolism. We report a case of a 42-year-old asymptomatic woman with right renal AML demonstrating progressive vascular invasion from the kidney to the IVC and RA over two years. The computed tomography (CT) scan revealed a fat-containing tumor with IVC and RA extension. Surgical management comprised right nephrectomy combined with tumor thrombectomy under cardiopulmonary bypass. The patient underwent successful radical resection without perioperative complications. Histopathological analysis confirmed AML, and postoperative follow-up showed no recurrence or residual tumor, with preserved renal function. This case underscores the rare but critical presentation of renal AML with vascular and cardiac extension, emphasizing the importance of comprehensive imaging for diagnosis and surgical planning. Despite its complexity, radical surgery offers favorable outcomes and is the preferred treatment to prevent life-threatening complications. Vigilant monitoring remains essential for timely intervention in similar cases.

Indexed as

inferior vena cava extensionrenal angiomyolipomaright atrial tumor thrombussurgical managementvascular invasion

Identifiers

PMID40979030
PMCPMC12446887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.